close

GRAACC and Biolab reinforce the importance of supporting the fight against childhood cancer

Published in November 04, 2024

Recognized for its work dedicated to the treatment, research and fight against childhood cancer, the GRAACC (Grupo de Apoio ao Adolescente e à Criança com Câncer) has cultivated a 33-year history of offering cutting-edge medical care and psychological support to children and adolescents, with the aim of guaranteeing every chance of being cured of childhood cancer, with quality of life. Biolab Farmacêutica believes in this cause and has been supporting the organization for over two decades, reinforcing its commitment to social responsibility and support for health causes.

"We support GRAACC's cause because we know the transformative power of health and the positive impact of humanizing treatment. We are proud to follow the institution's achievements closely. GRAACC is a center of excellence in the treatment of children, offering not only medical care, but also hospitality and comfort to the patients' families," says Tati Marques, Director of Corporate Communication and Sustainability at Biolab Farmacêutica.

"Biolab is a great partner of GRAACC, which has supported us for almost 20 years and contributes to our daily work of bringing treatment and care to thousands of children and their families. One of the main actions is during the McDia Feliz campaign, which takes place every year and, in addition to helping our hospital raise more funds, Biolab multiplies the benefit to many more people by distributing the tickets to its employees and their families," says Dr. Sergio Petrilli, pediatric oncologist and one of the founders of GRAACC.

With this initiative, Biolab is strengthening its role not only as a company focused on pharmaceutical innovation, but also as an active agent in promoting health and social well-being. The partnership symbolizes the joining of forces for the sake of life and the hope of a better future for children and adolescents undergoing treatment.

Service:

Do you want to be part of this chain of good? Visit the link  https://graacc.org.br/doar/ and find out how your donation can help others!

About Biolab

Promoting a future with a better quality of life requires a tireless search for safe and innovative treatments. With this mission in mind, Biolab, a Brazilian pharmaceutical company founded in 1997 and with an international presence, invests in research and partnerships to overcome the growing challenges of health.

With more than 3,800 employees and the 4th largest sales force in Brazil, Biolab is among the largest pharmaceutical companies in the country, operating in various specialties, such as dermatology, gynecology, orthopedics, gastroenterology, pediatrics, clinical medicine and the central nervous system, as well as being a leader in cardiology. The Biolab Genéricos, Avert Humana and Avert Biolab Saúde Animal business units contribute to a portfolio of more than 500 products.

Biolab is constantly growing. It has three production units, as well as a modern manufacturing complex under construction. And it doesn't stop there: in Canada it is the first Brazilian pharmaceutical company with a Research Center and it acquired the company Exzell Pharma to expand its borders.

Long live evolution!

Find out more at www.biolabfarma.com.br and on social media: Instagram, Facebook and Linkedin.

Copyright © Biolab | Rights Reserved - 2024